skip to primary navigationskip to content

Our Vision

Cardiovascular disease is a huge burden to healthcare systems around the world. It is the number one killer in UK, and is expected to become the most common cause of death globally by 2020. Diagnosis, prevention and treatment of cardiovascular disease within our aging populations will be among the most pressing challenges in this century.

Our Vision

We will transform Cambridge into a world-leading hub for cardiovascular research. The foundation for this is provided by the integration of high quality pre-clinical and clinical research operating in a University-Hospital-Industry partnership.

This will be aided by the re-location of Papworth hospital and AstraZeneca global headquarters and R&D facilities to Cambridge Biomedical Campus, and will be further strengthened by the foundation of a dedicated Cambridge Heart & Lung Research Institute (HLRI), for which fundraising is ongoing.


Cambridge Cardiovascular logo - transparent

Logo design by Dr Ana-Mishel Spiroski and Dr Sarah Morgan.


We connect cardiovascular researchers in Cambridge.

Please follow us on Twitter for local news about research, events, funding calls, and open positions.

For inquiries about our research or the website, please contact Dr Katja Kivinen.